These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 30445734)

  • 61. Isolation and quantification of botulinum neurotoxin from complex matrices using the BoTest matrix assays.
    Dunning FM; Piazza TM; Zeytin FN; Tucker WC
    J Vis Exp; 2014 Mar; (85):. PubMed ID: 24638074
    [TBL] [Abstract][Full Text] [Related]  

  • 62. RNA aptasensor for rapid detection of natively folded type A botulinum neurotoxin.
    Janardhanan P; Mello CM; Singh BR; Lou J; Marks JD; Cai S
    Talanta; 2013 Dec; 117():273-80. PubMed ID: 24209341
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Rapid and Sensitive Nano-Immunosensors for Botulinum.
    Cheng HP; Chuang HS
    ACS Sens; 2019 Jul; 4(7):1754-1760. PubMed ID: 31144807
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Preparation of egg yolk antibodies against BoNT/B and their passive protection in mouse models.
    You Z; Yang H; Xin W; Kang L; Gao S; Wang J; Zhang T; Wang J
    Hum Vaccin Immunother; 2014; 10(8):2321-7. PubMed ID: 25424938
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A new peptide substrate for enhanced botulinum neurotoxin type B detection by endopeptidase-liquid chromatography-tandem mass spectrometry/multiple reaction monitoring assay.
    Rosen O; Feldberg L; Gura S; Zichel R
    Anal Biochem; 2015 Mar; 473():7-10. PubMed ID: 25277815
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Isolation and functional characterization of the novel Clostridium botulinum neurotoxin A8 subtype.
    Kull S; Schulz KM; Weisemann J; Kirchner S; Schreiber T; Bollenbach A; Dabrowski PW; Nitsche A; Kalb SR; Dorner MB; Barr JR; Rummel A; Dorner BG
    PLoS One; 2015; 10(2):e0116381. PubMed ID: 25658638
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Monoclonal Antibodies that Inhibit the Proteolytic Activity of Botulinum Neurotoxin Serotype/B.
    Fan Y; Dong J; Lou J; Wen W; Conrad F; Geren IN; Garcia-Rodriguez C; Smith TJ; Smith LA; Ho M; Pires-Alves M; Wilson BA; Marks JD
    Toxins (Basel); 2015 Aug; 7(9):3405-23. PubMed ID: 26343720
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Regulation of Botulinum Neurotoxin Synthesis and Toxin Complex Formation by Arginine and Glucose in Clostridium botulinum ATCC 3502.
    Fredrick CM; Lin G; Johnson EA
    Appl Environ Microbiol; 2017 Jul; 83(13):. PubMed ID: 28455330
    [TBL] [Abstract][Full Text] [Related]  

  • 69. In-Vivo Neutralization of Botulinum Neurotoxin Serotype E Using Rabbit Polyclonal Antibody Developed against BoNT/E Light Chain.
    Rani S; Ponmariappan S; Sharma A; Kamboj DV; Jain AK
    Protein Pept Lett; 2017; 24(6):495-502. PubMed ID: 28260503
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Development of aequorin-based mast cell nanosensor for rapid identification of botulinum neurotoxin type B.
    Xin W; Yao W; Gao X; You Z; Gao S; Kang L; Li Q; Zhou Y; Yang H; Jiang P; Wang J
    J Biomed Nanotechnol; 2014 Nov; 10(11):3318-28. PubMed ID: 26000390
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Inhibiting oral intoxication of botulinum neurotoxin A complex by carbohydrate receptor mimics.
    Lee K; Lam KH; Kruel AM; Mahrhold S; Perry K; Cheng LW; Rummel A; Jin R
    Toxicon; 2015 Dec; 107(Pt A):43-9. PubMed ID: 26272706
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Nanopore sensing of botulinum toxin type B by discriminating an enzymatically cleaved Peptide from a synaptic protein synaptobrevin 2 derivative.
    Wang Y; Montana V; Grubišić V; Stout RF; Parpura V; Gu LQ
    ACS Appl Mater Interfaces; 2015 Jan; 7(1):184-92. PubMed ID: 25511125
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Purification and Characterization of Botulinum Neurotoxin FA from a Genetically Modified Clostridium botulinum Strain.
    Pellett S; Tepp WH; Bradshaw M; Kalb SR; Dykes JK; Lin G; Nawrocki EM; Pier CL; Barr JR; Maslanka SE; Johnson EA
    mSphere; 2016; 1(1):. PubMed ID: 27303710
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Biosensor immunoassay of ivermectin in bovine milk.
    Samsonova JV; Baxter GA; Crooks SR; Elliott CT
    J AOAC Int; 2002; 85(4):879-82. PubMed ID: 12180682
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Development and optimization of immunoassays for the detection of botulinum toxins].
    Titov AA; Shilenko IV; Morozov AA; Iarkov SP; Zlobin VN
    Prikl Biokhim Mikrobiol; 2012; 48(2):249-56. PubMed ID: 22586920
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Production and evaluation of a recombinant subunit vaccine against botulinum neurotoxin serotype B using a 293E expression system.
    Yu Y; Shi D; Liu S; Gong ZW; Wang S; Sun Z
    Hum Vaccin Immunother; 2015; 11(2):468-73. PubMed ID: 25483668
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Expression, purification and development of neutralizing antibodies from synthetic BoNT/B LC and its application in detection of botulinum toxin serotype B.
    Ponmariappan S; Jain S; Sijoria R; Tomar A; Kumar O
    Protein Pept Lett; 2012 Mar; 19(3):288-98. PubMed ID: 21933129
    [TBL] [Abstract][Full Text] [Related]  

  • 78. New approach for the rational selection of markers to identify botulinum toxins.
    Rosen O; Feldberg L; Dor E; Zichel R
    Arch Toxicol; 2021 Apr; 95(4):1503-1516. PubMed ID: 33569691
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Applications of array biosensor for detection of food allergens.
    Shriver-Lake LC; Taitt CR; Ligler FS
    J AOAC Int; 2004; 87(6):1498-502. PubMed ID: 15675465
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Dual-route targeted vaccine protects efficiently against botulinum neurotoxin A complex.
    Sahay B; Colliou N; Zadeh M; Ge Y; Gong M; Owen JL; Valletti M; Jobin C; Mohamadzadeh M
    Vaccine; 2018 Jan; 36(1):155-164. PubMed ID: 29180028
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.